DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study

NCT05727579 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Diabetic Kidney Disease
Hypertension

Interventions

OTHER: Salt-Diet and/or Ertugliflozin
DRUG: Ertugliflozin 15 mg

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]
[object Object]